CFM
MRNA icon

Crawford Fund Management’s Moderna MRNA Stock Holding History

Crawford Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.04M Sell
158,200
-88,800
-36% -$4.14M 1.55% 23
2025
Q4 		$7.28M Sell
247,000
-13,600
-5% -$369K 0.96% 26
2025
Q3 		$6.73M Buy
260,600
+60,500
+30% +$1.69M 1.08% 28
2025
Q2 		$5.52M Buy
200,100
+15,500
+8% +$408K 1.03% 29
2025
Q1 		$5.23M Buy
184,600
+34,000
+23% +$1.21M 1.25% 25
2024
Q4 		$6.26M Sell
150,600
-46,000
-23% -$2.2M 1.09% 20
2024
Q3 		$13.1M Buy
196,600
+59,300
+43% +$5.44M 2.82% 3
2024
Q2 		$16.3M Buy
137,300
+8,200
+6% +$1.04M 4.12% 2
2024
Q1 		$13.8M Buy
129,100
+21,300
+20% +$2.15M 3.3% 2
2023
Q4 		$10.7M Buy
+107,800
New +$9.07M 2.13% 4

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return